Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens.
Department of Ophthalmology, University of Florida College of Medicine, Gainesville, FL.
J Glaucoma. 2022 Sep 1;31(9):744-750. doi: 10.1097/IJG.0000000000002056. Epub 2022 Jun 2.
Bleb-related endophthalmitis (BRE) is a serious complication of glaucoma filtration surgery. The current study reports similar visual and intraocular pressure (IOP) outcomes in eyes treated with pars plana vitrectomy (PPV) compared with vitreous biopsy and injection of intravitreal antibiotics (TI).
The purpose of this study was to investigate the isolated organisms, visual acuity (VA), and IOP outcomes associated with delayed-onset BRE in eyes treated with PPV versus TI.
A retrospective chart review was conducted at the Bascom Palmer Eye Institute (Miami, Florida) and the University of Florida (Gainesville, FL) identifying patients treated for BRE with at least 1 month of follow-up from the inception of an electronic health record (2014 and 2011, respectively) through 2021. All patients had undergone bleb-forming glaucoma surgery at least 1 month before endophthalmitis diagnosis.
Thirty-nine eyes from 39 patients (33 from Bascom Palmer, 6 from University of Florida) were included. Trabeculectomy was performed in 34 of 39 eyes (87.2%). Streptococcus species (9 eyes, 23.1%) and Staphylococcus species (8 eyes, 20.5%) were the most common isolated organisms and were similar in both treatment groups ( P =0.49). Baseline VA was worse in the PPV group (logarithm of the minimum angle of resolution: 2.51 vs. 2.16, P =0.04), but VA at last follow-up was similar ( P =0.48) in both groups. After recovery from BRE, the average IOP in the PPV group was 15.1 mm Hg on 0.9 IOP-lowering medications compared with 12.6 mm Hg on 1.2 medications in the TI group (IOP: P =0.56; medications: P =0.80). Additional glaucoma surgery was performed in 44.4% of the PPV eyes and 16.7% of the TI eyes ( P =0.09).
In eyes with delayed-onset BRE, isolated organisms, visual outcomes, and IOP control were similar after initial PPV compared with TI.
青光眼滤过性手术相关眼内炎(BRE)是一种严重的并发症。本研究报告称,与玻璃体活检和玻璃体内注射抗生素(TI)相比,接受玻璃体切除术(PPV)治疗的眼睛具有相似的视力和眼内压(IOP)结果。
本研究旨在研究与接受 PPV 治疗的眼睛中迟发性 BRE 相关的分离病原体、视力(VA)和 IOP 结果与接受 TI 治疗的眼睛相比。
在迈阿密的 Bascom Palmer 眼科研究所(佛罗里达州迈阿密)和佛罗里达州盖恩斯维尔的佛罗里达大学(佛罗里达州盖恩斯维尔)进行了回顾性图表审查,确定了至少在电子病历开始后 1 个月(分别为 2014 年和 2011 年)至 2021 年接受 BRE 治疗且随访时间至少 1 个月的患者。所有患者在诊断眼内炎前至少 1 个月接受了致滤过泡性青光眼手术。
纳入了 39 名患者(33 名来自 Bascom Palmer,6 名来自佛罗里达大学)的 39 只眼。39 只眼中有 34 只(87.2%)行小梁切除术。最常见的分离病原体为链球菌属(9 只眼,23.1%)和葡萄球菌属(8 只眼,20.5%),且在两组中的比例相似(P=0.49)。PPV 组的基线 VA 较差(最小分辨角对数:2.51 与 2.16,P=0.04),但两组的最后随访时 VA 相似(P=0.48)。在 BRE 恢复后,PPV 组的平均 IOP 为 15.1mmHg,使用 0.9 种降眼压药物,而 TI 组为 12.6mmHg,使用 1.2 种药物(IOP:P=0.56;药物:P=0.80)。PPV 眼中有 44.4%和 TI 眼中有 16.7%需要进行额外的青光眼手术(P=0.09)。
在迟发性 BRE 眼中,与 TI 相比,初始接受 PPV 治疗后,分离病原体、视力结果和 IOP 控制情况相似。